ADC Therapeutics S.A. (ADCT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 276.77M | 306.33M | 287.15M | 318.75M | 257.99M | 307.39M | 333M | 355.36M | 290.21M | 336.29M | 375.6M | 412.81M |
| Cash & Short-Term Investments | 231.01M | 261.34M | 234.74M | 264.56M | 194.7M | 250.87M | 274.27M | 300.12M | 234.28M | 278.6M | 310.41M | 347.51M |
| Cash Only | 231.01M | 261.34M | 234.74M | 264.56M | 194.7M | 250.87M | 274.27M | 300.12M | 234.28M | 278.6M | 310.41M | 347.51M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 31.05M | 29.12M | 22.92M | 26.18M | 31.76M | 20.32M | 24.03M | 22.87M | 23.19M | 25.18M | 21.18M | 23.87M |
| Days Sales Outstanding | 129.84 | 103.81 | 137.5 | 139.95 | 101.75 | 120.63 | 116.84 | 120.36 | 121.9 | 127.02 | 142.97 | 113.03 |
| Inventory | 4.78M | 4.18M | 18.04M | 17.76M | 17.45M | 18.39M | 16.07M | 15.19M | 16M | 16.18M | 22.73M | 19.43M |
| Days Inventory Outstanding | 111.54 | 601.76 | 1.37K | 1.92K | 782.4 | 1.16K | 1.69K | 1.17K | 583.23 | 14.3 | 5.3K | 1.51K |
| Other Current Assets | 9.94M | 11.7M | 5.52M | 5.66M | 7.18M | 9.45M | 18.63M | 17.18M | 16.74M | 5.99M | 21.28M | 22M |
| Total Non-Current Assets | 14.73M | 16.82M | 2.61M | 2.81M | 14.55M | 14.59M | 16.07M | 16.42M | 17.76M | 18.49M | 91.3M | 94.49M |
| Property, Plant & Equipment | 1.2M | 1.3M | 1.39M | 1.49M | 13.39M | 13.43M | 14.91M | 15.17M | 15.84M | 16.13M | 15.53M | 16.37M |
| Fixed Asset Turnover | 16.70x | 17.14x | 11.40x | 2.53x | 1.72x | 1.19x | 1.23x | 1.12x | 1.13x | 1.06x | 0.91x | 1.20x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.36M | 13.54M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 260K | 930K | 1.65M | 26.99M | 28.32M |
| Other Non-Current Assets | 13.53M | 15.52M | 1.22M | 1.32M | 1.16M | 1.16M | 1.17M | 992K | 986K | 711K | 1.02M | 1.44M |
| Total Assets | 291.5M | 323.15M | 289.76M | 321.56M | 272.54M | 321.98M | 349.08M | 371.78M | 307.97M | 354.78M | 466.9M | 507.3M |
| Asset Turnover | 0.07x | 0.08x | 0.05x | 0.06x | 0.08x | 0.05x | 0.05x | 0.05x | 0.05x | 0.04x | 0.03x | 0.04x |
| Asset Growth % | 6.96% | 0.36% | -16.99% | -13.51% | -11.5% | -9.25% | -25.23% | -26.71% | -34.15% | -27.72% | -12.2% | -2.53% |
| Total Current Liabilities | 67.63M | 70.16M | 62.04M | 64.6M | 57.79M | 80.47M | 67.68M | 57.63M | 62.98M | 67.67M | 78.21M | 80.58M |
| Accounts Payable | 5.29M | 9.18M | 8.12M | 9.62M | 15.59M | 18.03M | 14.37M | 10.71M | 14.31M | 15.57M | 8.98M | 11.69M |
| Days Payables Outstanding | 180.12 | 468.23 | 678.71 | 1.37K | 734.08 | 1.09K | 1.36K | 935.54 | 541.72 | 9.02 | 2.6K | 819.36 |
| Short-Term Debt | 4.63M | 3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.33M | 13.86M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 57.7M | 57.99M | 17.49M | 18.89M | 9.41M | 26.95M | 11.76M | 10.94M | 41.21M | 37.94M | 53.48M | 53.4M |
| Current Ratio | 4.09x | 4.37x | 4.63x | 4.93x | 4.46x | 3.82x | 4.92x | 6.17x | 4.61x | 4.97x | 4.80x | 5.12x |
| Quick Ratio | 4.02x | 4.31x | 4.34x | 4.66x | 4.16x | 3.59x | 4.68x | 5.90x | 4.35x | 4.73x | 4.51x | 4.88x |
| Cash Conversion Cycle | 61.25 | 237.34 | 829.03 | 684.32 | 150.06 | 189.68 | 451.05 | 350.85 | 163.42 | 132.3 | 2.84K | 808.11 |
| Total Non-Current Liabilities | 440.25M | 438.82M | 465.9M | 456.14M | 452.97M | 444.15M | 453.35M | 445.82M | 439.43M | 435.36M | 442.88M | 435.31M |
| Long-Term Debt | 416.72M | 436.01M | 115.21M | 114.47M | 440.62M | 113.63M | 114.19M | 113.67M | 113.23M | 112.73M | 97.71M | 97.36M |
| Capital Lease Obligations | 0 | 1.03M | 1.13M | 1.26M | 7.91M | 8M | 8.88M | 9.31M | 9.66M | 10.18M | 10.08M | 10.76M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 23.52M | 2.81M | 349.56M | 340.41M | 4.45M | 2.43M | 7.65M | 322.83M | 6.52M | 312.45M | 311.55M | 303.65M |
| Total Liabilities | 507.87M | 508.98M | 527.94M | 520.75M | 510.76M | 524.62M | 521.02M | 503.45M | 502.42M | 503.03M | 521.08M | 515.89M |
| Total Debt | 421.36M | 439.01M | 117.27M | 117.52M | 449.89M | 123M | 124.55M | 124.4M | 124.33M | 124.38M | 123.53M | 123.61M |
| Net Debt | 190.35M | 177.67M | -117.47M | -147.04M | 255.19M | -127.87M | -149.72M | -175.72M | -109.96M | -154.22M | -186.88M | -223.9M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -2.04x | 0.48x | -2.06x | -3.26x | -2.17x | -1.65x | -2.33x | -1.82x | -2.66x | -5.21x | -2.61x | -4.11x |
| Total Equity | -216.38M | -185.83M | -238.18M | -199.18M | -238.22M | -202.64M | -171.95M | -131.67M | -194.45M | -148.25M | -54.18M | -8.59M |
| Equity Growth % | 9.17% | 8.29% | -38.52% | -51.28% | -22.51% | -36.69% | -217.35% | -1433.01% | -615.99% | -286.59% | -151.71% | -107.45% |
| Book Value per Share | -1.40 | -1.24 | -1.75 | -1.75 | -2.22 | -1.92 | -1.64 | -1.38 | -2.36 | -1.80 | -0.66 | -0.11 |
| Total Shareholders' Equity | -216.38M | -185.83M | -238.18M | -199.18M | -238.22M | -202.64M | -171.95M | -131.67M | -194.45M | -148.25M | -54.18M | -8.59M |
| Common Stock | 11.23M | 11.08M | 9.76M | 9.75M | 8.44M | 8.43M | 8.23M | 8.23M | 7.31M | 7.31M | 7.31M | 7.31M |
| Retained Earnings | -1.67B | -1.64B | -1.63B | -1.59B | -1.53B | -1.49B | -1.46B | -1.42B | -1.38B | -1.34B | -1.24B | -1.19B |
| Treasury Stock | 0 | -205K | -205K | -207K | -207K | -220K | -222K | -239K | -502K | -541K | -541K | -557K |
| Accumulated OCI | -802K | -517K | -702K | -388K | -1.09M | -1.42M | 203K | -338K | -201K | -93K | 166M | 164.13M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |